NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Comprehensive Segmental Revision System
Comprehensive Segmental Revision System

NCT03270982

Active Not RecruitingN/A

Sponsor: Zimmer Biomet

Conditions: Degenerative Disease, Oncology, Revision Surgery, Trauma, Rheumatoid Arthritis

Interventions: Comprehensive SRS Replacement

Countries: Canada, Denmark, United Kingdom

Clinical Data evaluation to document the performance and clinical outcomes of the Comprehensive Segmental Revision System.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Non Inflammatory Degenerative joint disease, including osteoarthritis, and avascular necrosis
* Rheumatoid arthritis
* Revision where other devices or treatments have failed
* Correction of functional deformity
* Oncology applications including bone loss due to tumour resection

Exclusion Criteria:

* Sepsis ( active)
* Infection ( active)
* Osteomyelitis (active)
Locations (4)
  • Halifax, Nova Scotia, Canada
  • Copenhagen, Denmark
  • Newport, Wales, United Kingdom
  • Liverpool, United Kingdom